78 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
may, among other things, include the Company's:
belief that chronic tendon injuries resulting from sports-related or occupational overuse … fails to provide a satisfactory solution to this chronic condition.
Treatment
The Company believes chronic tendon injuries resulting from sports-related
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
focused on developing autologous cell therapies that treat functional cellular deficits including chronic tendon injuries, androgenetic alopecia and skin
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
cellular deficits including chronic tendon injuries, androgenetic alopecia and skin aging.
The Company's corporate office and principal place
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
things, include the Company's:
belief that chronic tendon injuries resulting from sports-related or occupational overuse is a significant unmet medical … to provide a satisfactory solution to this chronic condition.
Treatment
The Company believes that chronic tendon injuries resulting from sports-related
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
therapies that treat functional cellular deficits including chronic tendon injuries, androgenetic alopecia and skin aging.
The address of the Company's
6-K
EX-99.2
7q3jimraf5
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
d6dta vnk3n29ubqk6
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
6o9lm vhh
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
ejizg s4ul95
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
cmdnq 376ynka
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
99jqqdwm27 old1q2
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
ftz7zigv1m2stcv
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
8xbiu0gbk8 j6myre4fo
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
db29veejhs
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
x8jfs8
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
bpizd rplp
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
twdxosqz7wzbuz
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
el92u4 4g2nekwy
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm